422 filings
Page 5 of 22
8-K
ncl 97dco3aj
17 Sep 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:31pm
8-K
u4ma8bkh6y
28 Jul 21
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results
4:06pm
8-K
wfp0tja
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
424B5
dekr8
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K/A
xmblf2zj
16 Jun 21
Submission of Matters to a Vote of Security Holders
6:05am
8-K
81stasr4hw 7mfm
3 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
93rj8v4bb4wm1r64p0
5 May 21
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:01pm
8-K
tfwupw7fijsk5
15 Apr 21
Other Events
12:00am
8-K
d1vq1ojb649 vu
8 Mar 21
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
4:01pm
8-K
qyi m77w0t
3 Mar 21
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year
4:01pm
EFFECT
25hmtu zhy
10 Feb 21
Notice of effectiveness
12:15am
8-K
q02nho8h6ghduatx
5 Feb 21
Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
8:01am
CORRESP
308ll3dy4q09yuir iab
5 Feb 21
Correspondence with SEC
12:00am
CORRESP
aj5 aokzn354zs385
2 Feb 21
Correspondence with SEC
12:00am
UPLOAD
3xp 54zzgtmj
28 Jan 21
Letter from SEC
12:00am